Cargando...
Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy
BACKGROUND: Etanercept and other anti-TNF-alpha agents have been indicated as a therapeutic option in severe drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Etanercept has been shown to quickly reduce the detachment of the epidermis and shorten healing time. Cases...
Gardado en:
| Publicado en: | J Dermatol Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Specjalisci Dermatolodzy
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844530/ https://ncbi.nlm.nih.gov/pubmed/27119002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2016.1224 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|